Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The European Medicines Group (EMG) is a professional industry association representing the UK-based operations of 22 research-based pharmaceutical companies headquartered in Europe. Established in 1993, the group provides a strategic forum for the managing directors of these companies to collaborate on policy, regulatory, and economic challenges within the UK healthcare landscape. EMG acts as a collective voice to engage with the UK government, the National Health Service (NHS), and other regulatory bodies to promote pharmaceutical innovation and improve patient access to treatments. The organization works in close partnership with the Association of the British Pharmaceutical Industry (ABPI) and the European Federation of Pharmaceutical Industries and Associations (EFPIA). Its member companies, including leaders like AstraZeneca, GSK, and Novartis, are major contributors to the UK's life sciences R&D and economic growth.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on European Medicines Group.